Naubourg, P.; El Osta, M.; Rageot, D.; Grunewald, O.; Renom, G.; Ducoroy, P.; Périni, J.-M.
A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform. Int. J. Neonatal Screen. 2019, 5, 10.
https://doi.org/10.3390/ijns5010010
AMA Style
Naubourg P, El Osta M, Rageot D, Grunewald O, Renom G, Ducoroy P, Périni J-M.
A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform. International Journal of Neonatal Screening. 2019; 5(1):10.
https://doi.org/10.3390/ijns5010010
Chicago/Turabian Style
Naubourg, Pierre, Marven El Osta, David Rageot, Olivier Grunewald, Gilles Renom, Patrick Ducoroy, and Jean-Marc Périni.
2019. "A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform" International Journal of Neonatal Screening 5, no. 1: 10.
https://doi.org/10.3390/ijns5010010
APA Style
Naubourg, P., El Osta, M., Rageot, D., Grunewald, O., Renom, G., Ducoroy, P., & Périni, J.-M.
(2019). A Multicentre Pilot Study of a Two-Tier Newborn Sickle Cell Disease Screening Procedure with a First Tier Based on a Fully Automated MALDI-TOF MS Platform. International Journal of Neonatal Screening, 5(1), 10.
https://doi.org/10.3390/ijns5010010